2025 Agenda
Wednesday, October 15
Time
Event
8:00 am – Lobby Level
Registration Opens
8:00 am – Ground Floor,
Event Hall South
One-to-One Meetings
8:55 am – 2nd Floor
Welcome Back
- Sara Jane Demy, Founder & CEO, Demy-Colton
9:00 am – 2nd Floor
“Big Think" Plenary Session
The New Policy Landscape: How it’s Benefiting the Sector
Moderator:
- Yeji Jesse Lee, Senior Healthcare Reporter, Law360
Panel:
- Jennifer Hawks Bland, CEO, NewYorkBIO
- Cartier Esham, CEO, Esham Strategies
- Nancy Myers, CEO & Founder, Catalyst Healthcare Consulting
- Peter Rubin, Executive Director, No Patient Left Behind
10:00 am – Ground Floor,
Event Hall South
One-to-One Meetings
10:00 am – 2nd Floor
Dialogue 4A
AI: From Target and Lead Discovery to Clinical Trials and Personalized Medicine – Revolutionizing Drug Development
Moderator:
- Rachel Ravens, Co-Founder & Managing Partner, 46Health
Panel:
- Ahmet-Hamdi Çavuşoğlu, Senior Director, Merck Digital Sciences Studio
- Vitalay Fomin, Co-Founder & CEO, Numenos
- Maria Pineda, CEO & Co-Founder, Envisagenics
11:00 am – 2nd Floor
Seed Pitch Doctor Presentations
Moderator:
- Jay Campbell, Life Sciences Executive, CBO, CFO, & Advisory Board Member
Pitch Doctors:
- Jessica Federer, Investor & Board Member, Angelini Ventures
- Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
- Stacey Seltzer, Managing Partner & Founder, Pontiva Healthcare Partners
12:15 pm – Ground Floor,
Event Hall South
Lunch
1:15 pm – 2nd Floor
“Big Think” Plenary Session
Venture Investment in Early-Stage Biopharma: Are We Seeing Signs of Recovery?
Moderator:
- Kelliann Payne, Partner, Global Regulatory, Hogan Lovells
Panel:
- Jessica Federer, Investor & Board Member, Angelini Ventures
- Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
2:15 pm – 2nd Floor
Closing “Big Think” Plenary Session
Heard Around the Street: What’s Buzzing in Biopharma
Moderator:
- Virginia Amman, CEO & Founder, ENTENTE Networks
Panel:
- Max Bayer, Pharma Reporter, Endpoints News
- Yeji Jesse Lee, Senior Healthcare Reporter, Law360
- Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News (GEN)
- Aayushi Pratap, Associate Editor, C&EN, American Chemical Society